Arrowhead Pharmaceuticals
ARWR
#2055
Rank
NZ$16.11 B
Marketcap
NZ$115.12
Share price
0.30%
Change (1 day)
222.51%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): NZ-$1.89

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$2.08. In 2024 the company made an earnings per share (EPS) of NZ-$8.30 a decrease over its 2023 EPS that were of NZ-$3.18.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$1.89-77.2%
2024NZ-$8.30161.39%
2023NZ-$3.1817.36%
2022NZ-$2.7119.85%
2021NZ-$2.2661.9%
2020NZ-$1.39-216.67%
2019NZ$1.20-210.77%
2018NZ-$1.0838.3%
2017NZ-$0.78-64.93%
2016NZ-$2.22-16.25%
2015NZ-$2.6628%
2014NZ-$2.08-3.85%
2013NZ-$2.16-31.58%
2012NZ-$3.15331.82%
2011NZ-$0.73-51.11%
2010NZ-$1.49-79.07%
2009NZ-$7.14-37.68%
2008NZ-$11.46-16.87%
2007NZ-$13.7838.33%
2006NZ-$9.96122.22%
2005NZ-$4.4842.11%
2004NZ-$3.15533.33%
2003NZ-$0.50-99.08%
2002NZ-$53.9125%
2001NZ-$43.1333.33%
2000NZ-$32.35-120%
1999NZ$161.73-400%
1998NZ-$53.91-81.48%
1997NZ-$291.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.33-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ-$13.40 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$3.97-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.15-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ-$4.78 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA